Simotinib hydrochloride
Modify Date: 2025-08-22 19:26:03
Simotinib hydrochloride structure
|
Common Name | Simotinib hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1538617-88-7 | Molecular Weight | 537.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H27Cl2FN4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Simotinib hydrochlorideSimotinib hydrochloride is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 19.9 nM. Antineoplastic activities[1]. |
| Name | Simotinib hydrochloride |
|---|
| Description | Simotinib hydrochloride is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 19.9 nM. Antineoplastic activities[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFR:19.9 nM (pIC50) |
| In Vitro | Simotinib hydrochloride inhibits in a dose-dependent manner EGFR and the growth of human A431 tumor cells with high expression of EGFR, with no significant activity on other investigated kinases[1]. |
| In Vivo | Simotinib hydrochloride has been shown to exert its antitumor activity by inhibiting EGFR phosphorylation in nude xenograft model[1]. |
| References |
| Molecular Formula | C25H27Cl2FN4O4 |
|---|---|
| Molecular Weight | 537.41 |
| InChIKey | RNEAUPHMDFWZDA-UHFFFAOYSA-N |
| SMILES | COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CC2)C2(C1)OCCO2.Cl |